ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Access to care"

  • Abstract Number: 1795 • ACR Convergence 2025

    Trends and Disparities in Osteoarthritis-Related Mortality in the United States: A 21-Year Analysis (1999-2020)

    muzamil Khan1, Swetha Balaji2, Ayesha Cheema3, Wajdan Ahmad3, Dhruv gandhi4 and Steven Golombek5, 1George Washington University School of Medicine and Health Sciences, Washington D.C, 2New York Medical College at St. Mary's General Hospital and St. Clare's Health, Parsippany-Troy Hills, NJ, 3Al Tibri Medical College, Karachi, Pakistan, 4St. Francis Medical Center, Monroe, 5NYMC at St. Mary's General Hospital and St. Clare's Health, Dover

    Background/Purpose: Osteoarthritis/arthrosis is an aging-related disease which is associated with significant morbidity in the United States. However, epidemiological data regarding osteoarthritis-associated mortality in the United…
  • Abstract Number: 1068 • ACR Convergence 2025

    Association Between Social Determinants of Health Domains and COVID-19-Related Hospitalization in Individuals with Autoimmune Rheumatic Diseases: A Retrospective Analysis of National U.S. Data

    Londyn Robinson1, jerrod anzalone2, Jasvinder Singh3, Kaleb Michaud2, Lesley Jackson4, Maria I. ("Maio") Danila5, Dongmei Li6, Rena Patel4 and Namrata Singh7, 1University of Washington, Seattle, WA, 2University of Nebraska Medical Center, Omaha, NE, 3Baylor College of Medicine, Houston, TX, 4University of Alabama at Birmingham, Birmingham, AL, 5University of Alabama at Birmingham (UAB), Birmingham VA Medical Center, Birmingham, AL, 6University of Rochester School of Medicine and Dentistry, Rochester, NY, 7University of Washington, Bellevue, WA

    Background/Purpose: Although studies have been published on the baseline characteristics of patients with autoimmune rheumatic diseases (AIRDs) with COVID-19 infection, little data exists on how…
  • Abstract Number: 0313 • ACR Convergence 2025

    People with Knee Osteoarthritis Infrequently Seek Medical Care for Arthritis, Even Those With Severe Disease

    Grace Lo1, Shunshun Yan2, Julieann Patarini3, Timothy McAlindon4, Charles Eaton5 and Jeffrey Driban6, 1Baylor College of Medicine / MEDVAMC, Houston, TX, 2Baylor College of Medicine, Houston, 3UMass Chan Medical School, Worcester, MA, 4UMass Chan School of Medicine, Arlington, MA, 5Brown University, Providence, RI, 6University of Massachusetts Chan Medical School, Marlborough, NH

    Background/Purpose: Osteoarthritis (OA) is the most common form of arthritis, a condition associated with substantial disability. Providers are often uncomfortable managing arthritis, and patients with…
  • Abstract Number: PP02 • ACR Convergence 2025

    When The Body Speaks But No One Listens: A Dermatomyositis Story Through a Public Health Lens

    Kyanna Johnson, Lynn Wilson, Manuel Lubinus, Elisa Glass

    Background/Purpose: My journey with dermatomyositis (DM) began abruptly in July 2024, when I was hit by sudden, severe muscle weakness after a GI infection. I…
  • Abstract Number: 2137 • ACR Convergence 2025

    Therapeutic Strategies in Newly Diagnosed Still’s Disease: Real-Life Clinicians’ Choices from the METAPHOR Project Worldwide Survey

    Francesco Baldo1, Greta Rogani2, Claudia Bracaglia3, Dirk Foell4, Marco Gattorno5, Jordi anton6, Paul Brogan7, Scott Canna8, randy Cron9, Alexiei GROM10, Merav Heshin Bekenstein11, Raju Khubchandani12, Seza Özen13, Pierre Quartier14, Angelo Ravelli15, Grant Schulert16, Mao Mizuta17, Joost Swart18, Rashmi Sinha19, AnnaCarin Horne20, Fabrizio De Benedetti21, Christiaan Scott22, Marija Jelusic23, Masaki Shimizu24, Bruno Fautrel25, Nicolino Ruperto26, Sebastiaan Vastert2 and Francesca Minoia27, 1ASST-Pini-CTO, Milano, Milan, Italy, 2University Medical Center Utrecht, Utrecht, Utrecht, Netherlands, 3IRCCS Ospedale Pediatrico Bambino Gesu', Rome, Rome, Italy, 4Universisty Hospital of Muenster, Muenster, 5IRCCS G. Gaslini, Genova, Genoa, Italy, 6Hospital Sant Joan de Düu. Universitat de Barcelona, Barcelona, Spain, 7UCL Institute of Child Health and Great Ormond Street Hospital NHS Foundation Trust, London, United Kingdom, 8Children's Hospital of Philadelphia, Philadelphia, PA, 9University of Alabama at Birmingham, Birmingham, AL, 10Cincinnati Children’s Hospital Medical Center, Division of Rheumatology, Cincinnati, OH, 11Tel Aviv Medical Center Israel, Binyamina, Tel Aviv, Israel, 12Jaslok Hospital and Research Center, Mumbai, India, 13Hacettepe University Medical Faculty, Ankara, Turkey, 14Hôpital Necker-Enfants Malades, Paris, France, 15IRCCS Istituto Giannina Gaslini, Genoa, Italy, Genoa, Genoa, Italy, 16Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 17Hyogo Prefectural Kobe Children's Hospital, Kobe, Japan, Kobe, Japan, 18Wilhelmina Children's Hospital / UMC Utrecht, Utrecht, Utrecht, Netherlands, 19Systemic JIA Foundation, Cincinnati, OH, 20Karolinska University Hospital, Sollentuna, Sweden, 21Bambino Gesu Children's Hospital, Rome, Rome, Italy, 22Childrens Hospital of Eastern Ontario (CHEO), Ottawa, ON, Canada, 23University of Zagreb School of Medicine, University Hospital Centre Zagreb, Zagreb, Zagreb, Croatia, 24Tokyo Medical and Dental University, Bunkyo-ku, Kanazawa, Japan, 25Sorbonne Université - APHP, Department of Rheumatology, Hôpital Pitié-Salpêtrière, Inserm UMRS 1136-5, PARIS, France, Paris, France, 26Université Milano Bicocca and Fondazione IRCSS S. Gerardo dei Tintori, Monza, Monza and Brianza, Italy, 27Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Milan, Italy

    Background/Purpose: Despite continuous advances in care and the recent publication of updated international recommendations, relevant discrepancies in the management of Still’s disease (SD) may still…
  • Abstract Number: 1706 • ACR Convergence 2025

    Overcoming Barriers to ANA Testing in Pediatric Populations in Africa

    Ekemini Ogbu1, Angela Migowa2, Rashmi Sahay1, Dhriti Sharma1, Patricia Vega-Fernandez1, Michael Henrickson1, Evans Omalla3, Ayodele Faleye4, Wafa Hamdi5 and Hermine Brunner1, 1Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Aga Khan University Medical College East Africa, Nairobi, Kenya, 3Pediatric Society of the African League Against Rheumatism, Nairobi, Kenya, 4Lagos state university teaching hospital Ikeja, Lagos, Lagos, Nigeria, 5Kassab Institute, Faculty of Medicine of Tunis UR17SP04, Tunis El Manar Univeristy, MANOUBA, Tunisia

    Background/Purpose: Timely diagnosis of children, adolescents and young adults with rheumatologic disorders remains a global challenge especially in lower resource countries and areas (LRCs). There…
  • Abstract Number: 1067 • ACR Convergence 2025

    Investigating Barriers to Care through Childhood Opportunity, Social Vulnerability, Area Deprivation, and Distance to Care in Pediatric Localized Scleroderma

    Karen Lin1, Yuhan Ma1, Simrat Morris2 and Kristina Ciaglia3, 1Scottish Rite for Children, Dallas, TX, 2UT Southwestern Medical Center and Scottish Rite for Children, Dallas, TX, 3UT Southwestern, Children's Medical Center, and Scottish Rite for Children, Dallas, TX

    Background/Purpose: Delays in diagnosis and treatment of pediatric localized scleroderma (LS) are common due to the under-recognition at initial presentation. While previous studies on pediatric…
  • Abstract Number: 0228 • ACR Convergence 2025

    Bridging the Gap: Leveraging eConsultation to Improve Access to Quality Gout Care

    Laura Nichols1 and Steven Taylor2, 1University of Colorado, Aurora, CO, 2University of Colorado, Denver, CO

    Background/Purpose: In the context of the rheumatology workforce shortage, eConsultation holds significant potential to address some challenges through supporting primary care providers in managing rheumatologic…
  • Abstract Number: 2680 • ACR Convergence 2025

    High Health Care Utilization Preceding Diagnosis of Juvenile Idiopathic Arthritis

    Anna Costello1, Rui Xiao1, Jahan Jazayeri1, Timothy Brandon1, Xuemei Zhang1, Irit Rasooly1 and Pamela Weiss2, 1Children's Hospital of Philadelphia, Philadelphia, PA, 2Childrens Hospital of Philadelphia, Philadelphia, PA

    Background/Purpose: Timely diagnosis of Juvenile Idiopathic Arthritis (JIA) enables early initiation of therapy and improves outcomes, yet JIA patients often experience circuitous pathways to diagnosis.…
  • Abstract Number: 2132 • ACR Convergence 2025

    The Bridge to Adult Care from Childhood for Young Adults with Rheumatic Disease (BACC YARD) Program, a Pediatric-To-Adult Rheumatology Transition Program, Reduces Median Time between Final Pediatric, First Adult, and Second Adult Visits

    Ayah Eltoum1, Eileen Rife2, Livie Timmerman3, Emily Smitherman4, Melissa Mannion4 and John Bridges5, 1University of Alabama at Birmingham, Hoover, AL, 2University of Alabama Birmingham, Vestavia Hills, AL, 3University of Alabama at Birmingham, Gardendale, AL, 4University of Alabama at Birmingham, Birmingham, AL, 5University of Alabama at Birmingham/Children's of Alabama, Birmingham, AL

    Background/Purpose: The transition from pediatric to adult-oriented rheumatology care is a critical period for young adults with childhood-onset rheumatic diseases. The Bridge to Adult Care…
  • Abstract Number: 1705 • ACR Convergence 2025

    Associations Between Social Risk Factors and Acute Care Use Among Patients with Rheumatic Conditions

    Haelynn Gim1, Leah Santacroce2, Rebecca Summit3, Karli Retzel4, Virginia Bills4, Nancy Shadick3, Sara Schoenfeld5 and Candace Feldman2, 1Harvard Medical School, Brookline, MA, 2Brigham and Women's Hospital, Boston, MA, 3Brigham & Women's Hospital, Boston, MA, 4Brigham & Women's Hospital, Boston, 5Massachusetts General Hospital, Boston, MA

    Background/Purpose: Adverse social determinants of health, or social risk factors (e.g., housing instability, food insecurity), contribute to disparities in rheumatic disease care and outcomes. Understanding…
  • Abstract Number: 1064 • ACR Convergence 2025

    Characterization of Juvenile Idiopathic Arthritis in Indigenous North American Children enrolled in a North American registry

    Hayley M Lynch1, Jordan E. Roberts1 and James N. Jarvis2, 1Seattle Children's Hospital/UW, Seattle, WA, 2University of Washington Center for Indigenous Health, Seattle, WA

    Background/Purpose: Several studies detail a higher prevalence and severity of juvenile idiopathic arthritis (JIA) in Indigenous North American (INA) children compared to the general population.…
  • Abstract Number: 0223 • ACR Convergence 2025

    Timely Dermatologic Diagnosis and Management Changes in Systemic Collagen Vascular Diseases: Experiences from the Rheumatology-Dermatology Combined Clinic

    Gopisree Peringeth1, Benedict Wu1, Shudan Wang2, Beth McLellan3, Clement Tagoe4 and Jeanie Lee1, 1Albert Einstein College of Medicine - Montefiore Medical Center, Bronx, NY, 2Montefiore Medical Center, Bronx, NY, 3Albert Einstein College of Medicine - Montefiore Medical Center, Bronx, 4Albert Einstein College of Medicine, FRESH MEADOWS, NY

    Background/Purpose: Collagen vascular diseases (CVD) often present with skin manifestations, but it is not always clear whether these changes are directly related to the underlying…
  • Abstract Number: 0273 • ACR Convergence 2024

    Barriers and Facilitators for Outpatient Follow-Up After an Acute Gout Flare: A Qualitative Research Study

    Elizabeth Lopez1, Lesley Jackson2, Kenneth Saag3 and Maria I. ("Maio") Danila4, 1University of Alabama at Birmingham, Montgomery, AL, 2University of Alabama at Birmingham, Birmingham, AL, 3The University of Alabama at Birmingham, Birmingham, AL, 4University of Alabama at Birmingham (UAB), Birmingham VA Medical Center, Birmingham, AL

    Background/Purpose: Many people with gout utilize the emergency department (ED) for acute gout care, but many do not receive subsequent adequate outpatient care for long-term…
  • Abstract Number: 1031 • ACR Convergence 2024

    Access to Advanced Therapies in Axial Spondyloarthritis in Latin America, Data from the PANLAR-ESPALDA Registry

    Rodrigo Garcia Salinas1, Fernando Andres Sommerfleck2, Diego Vila3, Daniel Palleiro4, Daniel Fernández-Ávila5, Julio César Casasola Vargas6, Maria Amada Barcia7, Dora Liliana Candia Zuniga8, Nicolas Martin Marin Zucaro9, María Lorena Brance10 and Wilson Bautista-Molano11, 1Hospital Italiano La Plata, La Plata, Argentina, 2Sanatorio Julio Mendez, Buenos Aires, Argentina, 3Hospital Virgen del Carmen, Campana, Buenos Aires, Argentina, 4Instituto Nacional de Reumatologia, Montevideo, Uruguay, 55Hospital San Ignacio, Colombia, BOGOTA, Colombia, 6Hospital General de México, “Dr.Eduardo Liceaga”, MEXICO CITY, Mexico, 77Hospital General Portoviejo del Instituto Ecuatoriano de Seguridad Social (IESS), Guayaquil, Ecuador, 88Hospital Regional Primero de Octubre ISSTE, Fuerzas Armadas, Mexico City, Mexico, 9Hospital Italiano de Buenos Aires, Capital Federal, Argentina, 10School of Medicine, Rosario National University, Argentina, Rosario, Argentina, 11University Hospital Fundación Santa Fe de Bogotá, Bogotá, Colombia

    Background/Purpose: Access to advanced treatments in LATAM poses challenges due to various socioeconomic factors. The PANLAR-ESPALDA registry was established with the objective of gathering data…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 29
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology